OptimizeRx Corp. (OPRX)
$8.43+2.55%Close
BUYRECOVERY · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $158M
- Beta
- 1.09
- P/E (TTM)
- 34.59
- Short % float
- 7.74%
- Days to cover
- 5.8
- SI change
- +10.6%
- 1W
- -4.31%
- 1M
- +7.94%
- vs SPY 1W
- -4.17%
- vs SPY 1M
- +5.43%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 76
- VALUE
- 38
- GROWTH
- 70
- GARP
- 97
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC2.2%
REV YoY-
ROE3.6%
EPS YoY-
ROA2.8%
GROSS72
OP11
NET5
[VALUATION]
P/E TTM34.59
P/E FWD8.82
SECTOR PE20.34
INDUSTRY PE24.21
P/B1.21
P/FCF-
EV/EBITDA9.75
EV/EBIT-
PEG0.43
FCF YIELD-
RISK
INT COV-
D/E14.86
ALTMAN Z-
CURR RATIO5.58
ND/EBITDA-
BETA1.09
Company news
FAQ
- What is LOPJLB’s current signal on OPRX?
- LOPJLB’s latest quantitative signal on OptimizeRx Corp. (OPRX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is OPRX in?
- OptimizeRx Corp. (OPRX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does OptimizeRx Corp. (OPRX) do?
- OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company w…